Plasma Exchange for Severe Attacks in the Spectrum of Central Demyelinating Disorders
Book:
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Page:
55-109
Author(s):
Mickael Bonnan and Philippe Cabre
GABAergic Neurotransmission and Alzheimer Disease: An Emerging Therapeutic Scenario?
Book:
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Page:
28-54
Author(s):
Mauricio O. Nava-Mesa, Lydia Jiménez-Diaz, Javier Yajeya and Juan D. Navarro-López
Schizophrenia Pharmacotherapy: Emerging Approaches
Book:
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Page:
3-27
Author(s):
Jaime Almeida and Christian Bouwkamp
List of Contributors
Book:
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Page:
iv-vii
Author(s):
Atta-ur-Rahman
Preface
Book:
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Page:
ii-iii
Author(s):
Atta-ur-Rahman
Foreword
Book:
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Page:
i-i
Author(s):
Ferid Murad
Index
Book:
Frontiers in Clinical Drug Research- Central Nervous System
Page:
229-245
Author(s):
Atta-ur-Rahman
Drugs Targeting Microglial Activation in Hypoxic Damage to the Developing White Matter
Book:
Frontiers in Clinical Drug Research- Central Nervous System
Page:
166-228
Author(s):
Gurugirijha Rathnasamy, Madhuvika Murugan, Eng-Ang Ling and Charanjit Kaur
Peptide Neurotoxins Targeting Voltage-Gated Ion Channels and Their Therapeutic Implications
Book:
Frontiers in Clinical Drug Research- Central Nervous System
Page:
100-165
Author(s):
Seungkyu Lee and Sun W. Hwang
Spinal Cord Injury: Clinical Trials and Translational Tribulations
Book:
Frontiers in Clinical Drug Research- Central Nervous System
Page:
61-99
Author(s):
Simon Harris, Jared Wilcox and Michael G. Fehlings